342 related articles for article (PubMed ID: 25427450)
1. Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer.
Buchholz S; Mögele M; Lintermans A; Bellen G; Prasauskas V; Ortmann O; Grob P; Neven P; Donders G
Climacteric; 2015 Apr; 18(2):252-9. PubMed ID: 25427450
[TBL] [Abstract][Full Text] [Related]
2. Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors.
Donders G; Bellen G; Neven P; Grob P; Prasauskas V; Buchholz S; Ortmann O
Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2023-8. PubMed ID: 26223323
[TBL] [Abstract][Full Text] [Related]
3. Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.
Donders G; Neven P; Moegele M; Lintermans A; Bellen G; Prasauskas V; Grob P; Ortmann O; Buchholz S
Breast Cancer Res Treat; 2014 Jun; 145(2):371-9. PubMed ID: 24718774
[TBL] [Abstract][Full Text] [Related]
4. Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy.
Jaisamrarn U; Triratanachat S; Chaikittisilpa S; Grob P; Prasauskas V; Taechakraichana N
Climacteric; 2013 Jun; 16(3):347-55. PubMed ID: 23347400
[TBL] [Abstract][Full Text] [Related]
5. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
Caruso S; Cianci S; Amore FF; Ventura B; Bambili E; Spadola S; Cianci A
Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974
[TBL] [Abstract][Full Text] [Related]
6. Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy.
Mariani L; Gadducci A; Vizza E; Tomao S; Vici P
Gynecol Endocrinol; 2013 Jan; 29(1):25-9. PubMed ID: 22994445
[TBL] [Abstract][Full Text] [Related]
7. Treatment of vaginal atrophy with estriol and lactobacilli combination: a clinical review.
Mueck AO; Ruan X; Prasauskas V; Grob P; Ortmann O
Climacteric; 2018 Apr; 21(2):140-147. PubMed ID: 29381086
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections.
Ozkinay E; Terek MC; Yayci M; Kaiser R; Grob P; Tuncay G
BJOG; 2005 Feb; 112(2):234-40. PubMed ID: 15663590
[TBL] [Abstract][Full Text] [Related]
9. Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients.
Pfeiler G; Glatz C; Königsberg R; Geisendorfer T; Fink-Retter A; Kubista E; Singer CF; Seifert M
Climacteric; 2011 Jun; 14(3):339-44. PubMed ID: 21226657
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial.
Hirschberg AL; Sánchez-Rovira P; Presa-Lorite J; Campos-Delgado M; Gil-Gil M; Lidbrink E; Suárez-Almarza J; Nieto-Magro C
Menopause; 2020 May; 27(5):526-534. PubMed ID: 32049923
[TBL] [Abstract][Full Text] [Related]
11. Effect of lyophilized lactobacilli and 0.03 mg estriol (Gynoflor®) on vaginitis and vaginosis with disrupted vaginal microflora: a multicenter, randomized, single-blind, active-controlled pilot study.
Donders GG; Van Bulck B; Van de Walle P; Kaiser RR; Pohlig G; Gonser S; Graf F
Gynecol Obstet Invest; 2010; 70(4):264-72. PubMed ID: 21051846
[TBL] [Abstract][Full Text] [Related]
12. Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial.
Melisko ME; Goldman ME; Hwang J; De Luca A; Fang S; Esserman LJ; Chien AJ; Park JW; Rugo HS
JAMA Oncol; 2017 Mar; 3(3):313-319. PubMed ID: 27832260
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
[TBL] [Abstract][Full Text] [Related]
14. Aromatase inhibitors affect vaginal proliferation and steroid hormone receptors.
Kallak TK; Baumgart J; Göransson E; Nilsson K; Poromaa IS; Stavreus-Evers A
Menopause; 2014 Apr; 21(4):383-90. PubMed ID: 24080848
[TBL] [Abstract][Full Text] [Related]
15. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.
Dugal R; Hesla K; Sørdal T; Aase KH; Lilleeidet O; Wickstrøm E
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):293-7. PubMed ID: 10746845
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J
Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
[TBL] [Abstract][Full Text] [Related]
17. Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors.
Davis SR; Robinson PJ; Jane F; White S; White M; Bell RJ
J Clin Endocrinol Metab; 2018 Nov; 103(11):4146-4154. PubMed ID: 30239842
[TBL] [Abstract][Full Text] [Related]
18. A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting.
Sánchez-Rovira P; Hirschberg AL; Gil-Gil M; Bermejo-De Las Heras B; Nieto-Magro C
Oncologist; 2020 Dec; 25(12):e1846-1854. PubMed ID: 32459035
[TBL] [Abstract][Full Text] [Related]
19. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
[TBL] [Abstract][Full Text] [Related]
20. The management of menopausal symptoms in breast cancer survivors: case-based approach.
Lammerink EA; de Bock GH; Schröder CP; Mourits MJ
Maturitas; 2012 Nov; 73(3):265-8. PubMed ID: 22883373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
